Skip to content
GEHCGE HealthCare

What Is GEHC Fair Value?

GE HealthCare (GEHC) fair value estimate using multiple valuation models, updated daily.

As of July 16, 2026, GE HealthCare (GEHC) has a composite fair value estimate of $55.62 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $63.20, suggesting the stock is fair value by 12.0%.

Data as of July 16, 2026 (today)

Composite Fair Value

Fair Value4 of 4 models

$55.62

vs. current price of $63.20(-12.0%)

Undervalued$55.62Overvalued
$63.20

How Is GEHC Fair Value Calculated?

Four independent models estimate what GEHC is worth. Each uses different inputs and assumptions. The composite blends them by weight.

GEHC Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$73.65

+16.5%

Undervalued

Inputs used

FCF: 1.6BGrowth: 8.1%Discount: 8%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$2.88

-95.4%

Overvalued

Inputs used

Dividend: $0.14/yrReq. Return: 9%Growth: 4.1%

GEHC Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$50.71

-19.8%

Overvalued

Inputs used

EPS: $4.87Book Value: $23.45

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$48.74

-22.9%

Overvalued

Inputs used

EPS: $4.87Growth: 8.1%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$73.65Undervalued

Current price $63.20 is 16.5% below this estimate

CheapFair ValueExpensive
8.1%
0.0%30.0%
7.7%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$1.69B$1.57B
Year 2$1.83B$1.57B
Year 3$1.98B$1.58B
Year 4$2.14B$1.59B
Year 5$2.31B$1.59B
Year 6$2.50B$1.60B
Year 7$2.70B$1.60B
Year 8$2.92B$1.61B
Year 9$3.15B$1.61B
Year 10$3.41B$1.62B
Terminal Value$66.90B$31.79B

What Are GEHC's Key Financial Metrics?

Earnings & Growth

Current Price

$63.20

EPS (TTM)

$4.27

Forward P/E

11.8

Profit Margin

9.1%

Cash & Balance Sheet

Free Cash Flow

1.5B

EBITDA

3.5B

Book Value

$23.45

Total Debt

10.6B

What Do Analysts Say About GEHC?

Low

$65.00

Average

$79.44

High

$98.00

Upside

+25.7%

Current $63.20Avg Target $79.44Buy18 analysts

GEHC Fair Value FAQ

What is the fair value of GEHC?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), GEHC's estimated fair value is $55.62. The stock is currently trading at $63.20, which makes it fair value by our analysis.

How is GEHC's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is GEHC overvalued or undervalued?

Based on our analysis, GEHC is fair value. The current price of $63.20 is 12.0% above our estimated fair value of $55.62.

What do Wall Street analysts say about GEHC?

18 analysts cover GE HealthCare with a consensus rating of "Buy." The average price target is $79.44, ranging from $65.00 to $98.00. This implies 25.7% upside from the current price.